##gff-version 3
##sequence-region Q9HCH0 1 1330
Q9HCH0	UniProtKB	Chain	1	1330	.	.	.	ID=PRO_0000288447;Note=Nck-associated protein 5-like	
Q9HCH0	UniProtKB	Region	1	135	.	.	.	Note=Mediates interaction with CDK5RAP2 and is required for homodimerization and microtubule bundle formation;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26482847,ECO:0000269|PubMed:26485573;Dbxref=PMID:26482847,PMID:26485573	
Q9HCH0	UniProtKB	Region	746	1142	.	.	.	Note=Mediates interaction with beta-tubulin and is required for microtubule bundle formation;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26482847;Dbxref=PMID:26482847	
Q9HCH0	UniProtKB	Coiled coil	24	102	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9HCH0	UniProtKB	Coiled coil	952	990	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9HCH0	UniProtKB	Motif	480	483	.	.	.	Note=(S/T)X(I/L)P motif 1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26482847,ECO:0000269|PubMed:26485573;Dbxref=PMID:26482847,PMID:26485573	
Q9HCH0	UniProtKB	Motif	812	815	.	.	.	Note=(S/T)X(I/L)P motif 2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26482847,ECO:0000269|PubMed:26485573;Dbxref=PMID:26482847,PMID:26485573	
Q9HCH0	UniProtKB	Motif	922	925	.	.	.	Note=(S/T)X(I/L)P motif 3%3B required for interaction with MAPRE1;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26482847,ECO:0000269|PubMed:26485573;Dbxref=PMID:26482847,PMID:26485573	
Q9HCH0	UniProtKB	Compositional bias	112	614	.	.	.	Note=Pro-rich	
Q9HCH0	UniProtKB	Compositional bias	784	875	.	.	.	Note=Pro-rich	
Q9HCH0	UniProtKB	Compositional bias	1042	1283	.	.	.	Note=Pro-rich	
Q9HCH0	UniProtKB	Modified residue	436	436	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:26549230;Dbxref=PMID:16964243,PMID:19690332,PMID:20068231,PMID:23186163,PMID:26549230	
Q9HCH0	UniProtKB	Modified residue	447	447	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:16964243,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:26549230;Dbxref=PMID:16964243,PMID:20068231,PMID:23186163,PMID:26549230	
Q9HCH0	UniProtKB	Modified residue	466	466	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26549230;Dbxref=PMID:26549230	
Q9HCH0	UniProtKB	Modified residue	473	473	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:26549230;Dbxref=PMID:18669648,PMID:23186163,PMID:26549230	
Q9HCH0	UniProtKB	Modified residue	489	489	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q9HCH0	UniProtKB	Modified residue	492	492	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231;Dbxref=PMID:18669648,PMID:20068231	
Q9HCH0	UniProtKB	Modified residue	494	494	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q9HCH0	UniProtKB	Modified residue	567	567	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:26549230;Dbxref=PMID:18669648,PMID:26549230	
Q9HCH0	UniProtKB	Modified residue	573	573	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26549230;Dbxref=PMID:26549230	
Q9HCH0	UniProtKB	Modified residue	655	655	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9HCH0	UniProtKB	Modified residue	763	763	.	.	.	Note=Phosphoserine%3B by CDK1;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:26549230;Dbxref=PMID:23186163,PMID:26549230	
Q9HCH0	UniProtKB	Modified residue	1190	1190	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9HCH0	UniProtKB	Alternative sequence	62	108	.	.	.	ID=VSP_033818;Note=In isoform 4. ANHVVQALLNQKDLREECIKLKKRVFDLERQNQMLSALFQQKLQLTT->CGSVVGLGGCGSSAPGRSWGQLMALPRGFLSPGCQPCGTGVAEPEGE;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9HCH0	UniProtKB	Alternative sequence	109	1330	.	.	.	ID=VSP_033819;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9HCH0	UniProtKB	Alternative sequence	771	792	.	.	.	ID=VSP_025677;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9HCH0	UniProtKB	Alternative sequence	1261	1330	.	.	.	ID=VSP_025678;Note=In isoform 2. ALPVDRKRSQEPSRPSPTPQGPPFGGSRTPSTSDMAEEGRVASGGPPGLETSESLSDSLYDSLSSCGSQG->VRIAAEERERTREQEGVMWGDQFLQ;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:10997877;Dbxref=PMID:10997877	
Q9HCH0	UniProtKB	Mutagenesis	482	483	.	.	.	Note=No decrease in localization to microtubule plus ends. Loss of interaction with MAPRE1 and localization to microtubule plus ends%3B when associated with 814-A-A-815 and 924-A-A-925. IP->AA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26482847,ECO:0000269|PubMed:26485573;Dbxref=PMID:26482847,PMID:26485573	
Q9HCH0	UniProtKB	Mutagenesis	814	815	.	.	.	Note=No decrease in localization to microtubule plus ends. Loss of interaction with MAPRE1 and localization to microtubule plus ends%3B when associated with 482-A-A-483 and 924-A-A-925. LP->AA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26482847,ECO:0000269|PubMed:26485573;Dbxref=PMID:26482847,PMID:26485573	
Q9HCH0	UniProtKB	Mutagenesis	924	925	.	.	.	Note=Loss of interaction with MAPRE1 and significantly reduced localization to microtubule plus ends. Loss of interaction with MAPRE1 and localization to microtubule plus ends%3B when associated with 482-A-A-483 and 814-A-A-815. LP->AA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26482847,ECO:0000269|PubMed:26485573;Dbxref=PMID:26482847,PMID:26485573	
Q9HCH0	UniProtKB	Sequence conflict	1093	1093	.	.	.	Note=T->M;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HCH0	UniProtKB	Sequence conflict	1093	1093	.	.	.	Note=T->M;Ontology_term=ECO:0000305;evidence=ECO:0000305	
